ATHNA BIOTECH
Athna Biotech specializes in developing novel nanotherapeutics for cancer. The SCNPs developed by Athna Biotech accurately target cancer cells, causing them to disintegrate and release tumor antigens as well as damage-associated molecular pattern molecules. These molecules help recruit dendritic cells, which leads to antigen-specific immunity. Because SCNPs are derived from a benign electrolyte, the side effects are minimal. Athna’s development addresses a gap in the market that BCG seems unable to fill. The global urothelial cancer drug market was valued at $855 million in 2017; it is expected to reach $3.6 billion by 2023. Athna is on track to compete for the NCI Experimental Therapeutics (NExT) program, bringing its drug closer to clinical use.
Similar Organizations
Abound Bio
Abound Bio specializes in generating antibody-based biological therapeutics to meet medical needs in the fields of cancer.
Apiquiet SPRL
Apiquiet SPRL specializes in the development of solutions and services that allow the elderly to live longer at home.
Arestyr OncoLogic
Arestyr OncoLogic is a biotechnology company that develops both diagnostics and therapies for cancer.
ENZYME BY DESIGN
ENZYME BY DESIGN specializes in safe cancer therapeutics services.
Kreatech Biotechnology
Kreatech Biotechnology is a agency that specializes in pathology solutions for medical businesses.
Menssana Research
Menssana Research is the leading developer of advanced new breath tests for detection of disease.
NasasBiotech
Biomedicine start-up developing and commercializing metastatic tumor cells capturing devices.
Project Mine
Project Mine specializes in the genetic research and consulting services of human DNA.
Sugen
Sugen specializes in target-driven drug discovery and development for novel development-stage cancer therapies.
Tavec pharma
Tavec Pharmaceuticals is developing injectable therapies to treat cancers.
More informations about "Athna Biotech"
Athna Biotech, Inc.
The company is located in a rapidly expanding biotechnology industrial and academic region, giving it a unique position at the forefront of advanced technology and biomaterial …See details»
Athna Biotech - Crunchbase Company Profile & Funding
Athna Biotech specializes in developing novel nanotherapeutics for cancer. The SCNPs developed by Athna Biotech accurately target cancer cells, causing them to disintegrate and …See details»
Policies - Athna Biotech, Inc.
The PI of each research project and the financial manager or administrator of Athna Biotech, Inc. will ensure and the subcontract organizations following the funding agency’s policy on …See details»
Athna Biotech, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Athna Biotech, Inc. of Watkinsville, GA. Get the latest business insights from Dun & Bradstreet.See details»
ATHNA BIOTECH INC - VentureRadar
Athna Biotech is a cutting-edge startup that was established by a team of biomedical researchers, engineers, and clinical scientists who specialize in life sciences, diagnostics, and the …See details»
Athna Biotech - Tech Stack, Apps, Patents & Trademarks
Athna Biotech specializes in developing novel nanotherapeutics for cancer.See details»
ATHNA BIOTECH INC | SBIR.gov
ABSTRACT Non–small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality. NSCLC accounts for 85% of all lung cancers, and is diagnosed in 234,030 persons each year …See details»
Athna Biotech - Crunchbase
Athna Biotech specializes in developing novel nanotherapeutics for cancer.See details»
Athna Biotech (LBCCTS71U2N4) - HigherGov
Federal grant recipient ATHNA BIOTECH INC (UEI LBCCTS71U2N4, CAGE 8CKB5) is headquartered in Watkinsville GA. Its primary registered NAICS is 541713 Research and …See details»
RePORT 〉 RePORTER
Awardee Organization ATHNA BIOTECH, INC. Description. Abstract Text. Abstract Bladder cancer comprises 7% of new cancer diagnoses in the US. It is the sixth most prevalent …See details»
RePORT 〉 RePORTER
Awardee Organization ATHNA BIOTECH, INC. Description. Abstract Text. ABSTRACT Non–small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality. NSCLC …See details»
Georgia Research Alliance - GRA
Athna Biotech Industry: Pharmaceutical cancer treatment. Athna Biotech specializes in developing novel nanotherapeutics for cancer. Their research in sodium chloride nanoparticles (SCNPs) …See details»
Contact | Athna Biotech, Inc.
Athna Biotech, Inc. 220 Riverbend Road, Riverbend south building 027, Athens, Georgia 30602, United States. 301-919-9067 [email protected]See details»
AmplifyBio shutters Bay Area site, lays off Ohio CRO staff
14 hours ago AmplifyBio is cutting costs, closing its R&D and characterization services site in South San Francisco and laying off employees in its Ohio-based preclinical CRO business, a …See details»
Mission and Leadership - ATHNA
You also may obtain information on charitable organizations from the New York State Office of the Attorney General at www.charitiesnys.com or (212) 416-8816. Donations to ATHNA are …See details»
ATHNA Fact Sheet
The American Association of Travel Health Nurses (ATHNA) celebrates its 20 th anniversary as a not-for-profit nursing professional organization in June 2024. Currently comprising more than …See details»
TEAM - Athna Biotech, Inc.
Advancing TherapeuticsSee details»
American Travel Health Nurses Association (ATHNA)
The American Travel Health Nurses Association (ATHNA) is the professional organization for the specialty of travel health nursing in North America. Founded in 2004, ATHNA is a 501 (c)(3) …See details»
Career - Athna Biotech, Inc.
At Athna Biotech, we are committed to maintaining the growth and success of our business by bringing in the best and brightest talent. We have a high-caliber team of innovative individuals, …See details»
News - Athna Biotech, Inc.
Jun 14, 2021 Athna Biotech, Inc. received a Phase I Small Business Innovation Research (SBIR) grant from NIH NCI to develop a salt-based nanomedicine for non-muscle invasive …See details»